Literature DB >> 33622401

Using GANs with adaptive training data to search for new molecules.

Andrew E Blanchard1, Christopher Stanley1, Debsindhu Bhowmik2.   

Abstract

The process of drug discovery involves a search over the space of all possible chemical compounds. Generative Adversarial Networks (GANs) provide a valuable tool towards exploring chemical space and optimizing known compounds for a desired functionality. Standard approaches to training GANs, however, can result in mode collapse, in which the generator primarily produces samples closely related to a small subset of the training data. In contrast, the search for novel compounds necessitates exploration beyond the original data. Here, we present an approach to training GANs that promotes incremental exploration and limits the impacts of mode collapse using concepts from Genetic Algorithms. In our approach, valid samples from the generator are used to replace samples from the training data. We consider both random and guided selection along with recombination during replacement. By tracking the number of novel compounds produced during training, we show that updates to the training data drastically outperform the traditional approach, increasing potential applications for GANs in drug discovery.

Entities:  

Keywords:  Drug discovery; Generative Adversarial Network; Search

Year:  2021        PMID: 33622401     DOI: 10.1186/s13321-021-00494-3

Source DB:  PubMed          Journal:  J Cheminform        ISSN: 1758-2946            Impact factor:   5.514


  14 in total

1.  Extended-connectivity fingerprints.

Authors:  David Rogers; Mathew Hahn
Journal:  J Chem Inf Model       Date:  2010-05-24       Impact factor: 4.956

2.  Quantifying the chemical beauty of drugs.

Authors:  G Richard Bickerton; Gaia V Paolini; Jérémy Besnard; Sorel Muresan; Andrew L Hopkins
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

Review 3.  Inverse molecular design using machine learning: Generative models for matter engineering.

Authors:  Benjamin Sanchez-Lengeling; Alán Aspuru-Guzik
Journal:  Science       Date:  2018-07-26       Impact factor: 47.728

Review 4.  The rise of deep learning in drug discovery.

Authors:  Hongming Chen; Ola Engkvist; Yinhai Wang; Marcus Olivecrona; Thomas Blaschke
Journal:  Drug Discov Today       Date:  2018-01-31       Impact factor: 7.851

5.  Molecular properties that influence the oral bioavailability of drug candidates.

Authors:  Daniel F Veber; Stephen R Johnson; Hung-Yuan Cheng; Brian R Smith; Keith W Ward; Kenneth D Kopple
Journal:  J Med Chem       Date:  2002-06-06       Impact factor: 7.446

6.  Stochastic voyages into uncharted chemical space produce a representative library of all possible drug-like compounds.

Authors:  Aaron M Virshup; Julia Contreras-García; Peter Wipf; Weitao Yang; David N Beratan
Journal:  J Am Chem Soc       Date:  2013-05-02       Impact factor: 15.419

7.  Deep learning enables rapid identification of potent DDR1 kinase inhibitors.

Authors:  Alex Zhavoronkov; Yan A Ivanenkov; Alex Aliper; Mark S Veselov; Vladimir A Aladinskiy; Anastasiya V Aladinskaya; Victor A Terentiev; Daniil A Polykovskiy; Maksim D Kuznetsov; Arip Asadulaev; Yury Volkov; Artem Zholus; Rim R Shayakhmetov; Alexander Zhebrak; Lidiya I Minaeva; Bogdan A Zagribelnyy; Lennart H Lee; Richard Soll; David Madge; Li Xing; Tao Guo; Alán Aspuru-Guzik
Journal:  Nat Biotechnol       Date:  2019-09-02       Impact factor: 54.908

8.  ZINC 15--Ligand Discovery for Everyone.

Authors:  Teague Sterling; John J Irwin
Journal:  J Chem Inf Model       Date:  2015-11-09       Impact factor: 4.956

View more
  1 in total

1.  Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation.

Authors:  Morgan Thomas; Noel M O'Boyle; Andreas Bender; Chris de Graaf
Journal:  J Cheminform       Date:  2022-10-03       Impact factor: 8.489

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.